Sentiment-Signal
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
HOCH Abgang Schlüsselpersonen (21.04.2026)
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 21.04.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | suant to Section 13(a) of the Exchange Act. o Item 5.02 Departure of Directors or Certain Officers; Election of Direc |
Stammdaten
Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. It cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, as well as through home delivery. The company produces flower, edible, vaporizer cartridge, concentrate, topical, capsule, tincture, dissolvable powder, and nasal spray products under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, and Roll One brands. As of March 16, 2022, it operated 162 dispensaries, which included 113 dispensaries in Florida, 19 affiliated dispensaries in Pennsylvania, 17 dispensaries in Arizona, five dispensaries in California, three dispensaries in Maryland, two dispensaries in Massachusetts, two dispensaries in West Virginia, and one dispensary in Connecticut. Trulieve Cannabis Corp. also operated cultivation and processing facilities in Arizona, Colorado, Florida, Maryland, Massachusetts, Nevada, Pennsylvania, and West Virginia. The company was formerly known as Schyan Exploration Inc./Exploration Schyan Inc. and changed its name to Trulieve Cannabis Corp. in September 2018. Trulieve Cannabis Corp. was incorporated in 1940 and is headquartered in Quincy, Florida.
Unternehmen & Branche
| Name | Trulieve Cannabis Corp. |
|---|---|
| Ticker | TCNNF |
| CIK | 0001754195 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Drug Manufacturers - Specialty & Generic |
| SIC | 2833 · Medicinal Chemicals & Botanical Products |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 1,83 Mrd. USD |
| Beta | 1,58 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 1,181,180,000 | -0.58 | 2,696,098,000 | ||
| 2025-09-30 | 10-Q | 288,187,000 | 2,941,618,000 | |||
| 2025-06-30 | 10-Q | 302,086,000 | 2,921,835,000 | |||
| 2025-03-31 | 10-Q | 297,760,000 | -0.16 | 2,887,641,000 | ||
| 2024-12-31 | 10-K | 1,186,490,000 | -0.79 | 2,870,269,000 | ||
| 2024-09-30 | 10-Q | 284,284,000 | -61,597,000 | -0.32 | 2,874,243,000 | |
| 2024-06-30 | 10-Q | 303,442,000 | -11,984,000 | -0.04 | 2,864,897,000 | |
| 2024-03-31 | 10-Q | 297,619,000 | -24,518,000 | -0.16 | 2,819,284,000 | |
| 2023-12-31 | 10-K | 1,129,193,000 | -2.28 | 2,729,055,000 | ||
| 2023-09-30 | 10-Q | 275,210,000 | -25,843,000 | -0.12 | 2,775,191,000 | |
| 2023-06-30 | 10-Q | 281,795,000 | -406,872,000 | -1.80 | 2,808,682,000 | |
| 2023-03-31 | 10-Q | 285,214,000 | -67,138,000 | -0.18 | 3,316,397,000 | |
| 2022-12-31 | 10-K | 1,218,229,000 | -252,727,000 | -0.95 | 3,400,405,000 | |
| 2022-09-30 | 10-Q | 295,353,000 | -115,072,000 | -0.38 | 3,320,958,000 | |
| 2022-06-30 | 10-Q | 313,839,000 | -24,021,000 | -0.09 | 3,464,266,000 | |
| 2022-03-31 | 10-Q | 317,747,000 | -32,482,000 | -0.16 | 3,525,854,000 | |
| 2021-12-31 | 10-K | 931,934,000 | 17,445,000 | 0.21 | 3,411,384,000 | |
| 2021-09-30 | 10-Q | 224,092,000 | 18,616,000 | 0.14 | 1,276,039,000 | 822,643,000 |
| 2021-06-30 | 10-Q | 215,122,000 | 40,880,000 | 0.31 | 1,161,080,000 | 758,290,000 |
| 2021-03-31 | 10-Q | 193,823,000 | 30,078,000 | 0.24 | 902,088,000 | 485,584,000 |
Fondsaktivität (Vorquartalsvergleich)
Insider-Transaktionen (12 Monate)
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.